🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MPM patients are not eligible for surgical procedures like decortication or...
Status
Completed
Location
University Hospital Zurich, Division of Oncology
Start Date
2015-02-19
Trial ID
NCT01722149
Treatments Being Tested
This phase I trial studies the side effects and how well giving autologous ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-01
Trial ID
NCT01477021
Treatments Being Tested
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Today there are no tests that allow to make a precise differential diagnosi...
Status
Completed
Location
IRCCS/AUSL Reggio Emilia Hospital
Start Date
2017-11-03
Trial ID
NCT03346018
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The primary objective of this study is to evaluate the prediction of late t...
Status
Completed
Location
CRLC Val d'Aurelle
Start Date
2006-06
Trial ID
NCT00893035
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-19
Trial ID
NCT04639245
This phase I/II trial studies the side effects and best way to give laborat...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2013-02
Trial ID
NCT01758458